These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33908356)

  • 21. Maintaining a Focus on Health Equity During the COVID-19 Vaccine Rollout.
    Martin EG; Birkhead GS; Holtgrave DR
    J Public Health Manag Pract; 2021 May-Jun 01; 27(3):226-228. PubMed ID: 33762538
    [No Abstract]   [Full Text] [Related]  

  • 22. COVID-19 and Moral Imperialism in Multinational Clinical Research.
    Hellmann F; Williams-Jones B; Garrafa V
    Arch Med Res; 2020 Aug; 51(6):572-573. PubMed ID: 32387041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Search for better COVID vaccines confounded by existing rollouts.
    Dolgin E
    Nature; 2021 Jan; 589(7842):340-341. PubMed ID: 33420405
    [No Abstract]   [Full Text] [Related]  

  • 24. Ethics and Professionalism on the Frontline: Controlled Human Infection Trials in COVID-19 Vaccine Development: Ethical Considerations.
    Lucido C
    S D Med; 2020 Oct; 73(10):490-492. PubMed ID: 33264530
    [No Abstract]   [Full Text] [Related]  

  • 25. WHO guidance on COVID-19 vaccine trial designs in the context of authorized COVID-19 vaccines and expanding global access: Ethical considerations.
    Singh JA; Kochhar S; Wolff J; Atuire C; Bhan A; Emanuel E; Faden R; Ghimire P; Greco D; Ho C; Moon S; Shamsi-Gooshki E; Touré A; Thomé B; Smith MJ; Upshur REG
    Vaccine; 2022 Mar; 40(14):2140-2149. PubMed ID: 35248422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COVID-19 vaccines: the importance of transparency and fact-based education.
    Cohen AF; van Gerven J; Burgos JG; de Boer A; Foucher RAM; Flore H; Teitelbaum Z; van Eden W; Webb A; Cremers S
    Br J Clin Pharmacol; 2020 Nov; 86(11):2107-2110. PubMed ID: 33464636
    [No Abstract]   [Full Text] [Related]  

  • 27. Review of Current Vaccine Development Strategies to Prevent Coronavirus Disease 2019 (COVID-19).
    Bennet BM; Wolf J; Laureano R; Sellers RS
    Toxicol Pathol; 2020 Oct; 48(7):800-809. PubMed ID: 32926660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ethical and Scientific Considerations Regarding the Early Approval and Deployment of a COVID-19 Vaccine.
    Dal-Ré R; Caplan AL; Gluud C; Porcher R
    Ann Intern Med; 2021 Feb; 174(2):258-260. PubMed ID: 33216636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current advances in the development of SARS-CoV-2 vaccines.
    Awadasseid A; Wu Y; Tanaka Y; Zhang W
    Int J Biol Sci; 2021; 17(1):8-19. PubMed ID: 33390829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Placebo use and unblinding in COVID-19 vaccine trials: recommendations of a WHO Expert Working Group.
    Singh JA; Kochhar S; Wolff J;
    Nat Med; 2021 Apr; 27(4):569-570. PubMed ID: 33727699
    [No Abstract]   [Full Text] [Related]  

  • 32. SARS-CoV-2: vaccines in the pandemic era.
    Li DD; Li QH
    Mil Med Res; 2021 Jan; 8(1):1. PubMed ID: 33402220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Placebo controls in clinical trials of new therapies for osteoporosis.
    Levine RJ
    J Bone Miner Res; 2003 Jun; 18(6):1154-9. PubMed ID: 12817775
    [No Abstract]   [Full Text] [Related]  

  • 34. Covid-19 Vaccine Trials and Incarcerated People - The Ethics of Inclusion.
    Strassle C; Jardas E; Ochoa J; Berkman BE; Danis M; Rid A; Taylor HA
    N Engl J Med; 2020 Nov; 383(20):1897-1899. PubMed ID: 33085884
    [No Abstract]   [Full Text] [Related]  

  • 35. Experts Discuss COVID-19: Vaccine Allocation, Placebo Groups, and More.
    JAMA; 2020 Dec; 324(23):2354-2355. PubMed ID: 33320222
    [No Abstract]   [Full Text] [Related]  

  • 36. COVID-19 Vaccines: Current Understanding on Immunogenicity, Safety, and Further Considerations.
    He Q; Mao Q; Zhang J; Bian L; Gao F; Wang J; Xu M; Liang Z
    Front Immunol; 2021; 12():669339. PubMed ID: 33912196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploration and Ethical Analysis of Open-label Pediatric Vaccine Trials in a Pandemic.
    Wolfe ID; Patel A; Kociolek LK; Fazal A; Jhaveri R; Lantos JD
    Clin Ther; 2021 Jun; 43(6):e163-e172. PubMed ID: 34039479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Covid-19: Chinese vaccines may need changes to improve efficacy, admits official.
    Dyer O
    BMJ; 2021 Apr; 373():n969. PubMed ID: 33849893
    [No Abstract]   [Full Text] [Related]  

  • 39. Controlled human infection with SARS-CoV-2 to study COVID-19 vaccines and treatments: bioethics in Utopia.
    Holm S
    J Med Ethics; 2020 Sep; 46(9):569-573. PubMed ID: 32616623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A cost/benefit analysis of clinical trial designs for COVID-19 vaccine candidates.
    Berry DA; Berry S; Hale P; Isakov L; Lo AW; Siah KW; Wong CH
    PLoS One; 2020; 15(12):e0244418. PubMed ID: 33362278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.